JPWO2021034689A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021034689A5 JPWO2021034689A5 JP2022509577A JP2022509577A JPWO2021034689A5 JP WO2021034689 A5 JPWO2021034689 A5 JP WO2021034689A5 JP 2022509577 A JP2022509577 A JP 2022509577A JP 2022509577 A JP2022509577 A JP 2022509577A JP WO2021034689 A5 JPWO2021034689 A5 JP WO2021034689A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- pharmaceutical composition
- domain
- amino acid
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962888055P | 2019-08-16 | 2019-08-16 | |
| US62/888,055 | 2019-08-16 | ||
| PCT/US2020/046439 WO2021034689A1 (en) | 2019-08-16 | 2020-08-14 | Anti-cd83 chimeric antigen receptor expressing t regulatory cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022544581A JP2022544581A (ja) | 2022-10-19 |
| JPWO2021034689A5 true JPWO2021034689A5 (ru) | 2023-08-18 |
Family
ID=74660009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022509577A Pending JP2022544581A (ja) | 2019-08-16 | 2020-08-14 | 抗ｃｄ３８キメラ抗原受容体を発現する制御性ｔ細胞 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220289862A1 (ru) |
| EP (1) | EP4013447A4 (ru) |
| JP (1) | JP2022544581A (ru) |
| CN (1) | CN114615992A (ru) |
| AU (1) | AU2020333659A1 (ru) |
| CA (1) | CA3147837A1 (ru) |
| WO (1) | WO2021034689A1 (ru) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114929341A (zh) * | 2019-08-16 | 2022-08-19 | H.李.莫菲特癌症中心和研究所股份有限公司 | 用于治疗髓系恶性肿瘤的嵌合抗原受体 |
| WO2023122643A1 (en) * | 2021-12-22 | 2023-06-29 | Regents Of The University Of Minnesota | Cd83 and allo- and autoimmune conditions |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040185040A1 (en) * | 2001-11-21 | 2004-09-23 | Celltech R & D Limited | Modulating immune responses |
| US9228172B2 (en) * | 2008-06-19 | 2016-01-05 | The Trustees Of The University Of Pennsylvania | Inducible regulatory T-cell generation for hematopoietic transplants |
| JP2013040160A (ja) * | 2011-07-01 | 2013-02-28 | Genentech Inc | 自己免疫疾患を治療するための抗ｃｄ８３アゴニスト抗体の使用 |
| JP2013150592A (ja) * | 2011-07-01 | 2013-08-08 | Genentech Inc | 自己免疫疾患を治療するための抗ｃｄ８３アゴニスト抗体の使用 |
| CA2899960C (en) * | 2013-02-01 | 2022-05-03 | Transbio Ltd | Anti-cd83 antibodies and use thereof |
| US20200281973A1 (en) * | 2016-03-04 | 2020-09-10 | Novartis Ag | Cells expressing multiple chimeric antigen receptor (car) molecules and uses therefore |
| JP7317023B2 (ja) * | 2017-09-20 | 2023-07-28 | ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア | 新規抗ｈｌａ－ａ２抗体、およびその使用 |
| WO2019136335A1 (en) * | 2018-01-05 | 2019-07-11 | Gencyte Therapeutics, Inc. | Precision molecular adaptor system for car-t immunotherapy |
| JP7422667B2 (ja) * | 2018-02-08 | 2024-01-26 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 同種造血幹細胞移植のための方法 |
| CA3092220A1 (en) * | 2018-02-23 | 2019-08-29 | Marco Davila | Cd83-binding chimeric antigen receptors |
-
2020
- 2020-08-14 CN CN202080063859.0A patent/CN114615992A/zh active Pending
- 2020-08-14 AU AU2020333659A patent/AU2020333659A1/en active Pending
- 2020-08-14 WO PCT/US2020/046439 patent/WO2021034689A1/en unknown
- 2020-08-14 US US17/635,119 patent/US20220289862A1/en active Pending
- 2020-08-14 JP JP2022509577A patent/JP2022544581A/ja active Pending
- 2020-08-14 CA CA3147837A patent/CA3147837A1/en active Pending
- 2020-08-14 EP EP20854296.9A patent/EP4013447A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021087455A5 (ru) | ||
| JP2021094037A5 (ru) | ||
| JP2019527557A5 (ru) | ||
| JP2019523301A5 (ru) | ||
| JP2021177771A5 (ru) | ||
| JP2020517295A5 (ru) | ||
| JP2020114264A5 (ru) | ||
| JP2017524367A5 (ru) | ||
| TW201920653A (zh) | 調節細胞表達的生物活性之結合分子 | |
| JP2020530289A5 (ru) | ||
| JP2020533958A5 (ru) | ||
| RU2020100865A (ru) | Лечение рака с помощью гуманизированного анти-cd19 химерного антигенного рецептора | |
| RU2020117196A (ru) | Химерный антигенный рецептор (car) против cd123 для использования в лечении злокачественных опухолей | |
| JP2018521628A5 (ru) | ||
| JPWO2016028896A5 (ru) | ||
| JP2024023228A5 (ru) | ||
| JP2020512973A5 (ru) | ||
| US20220184127A1 (en) | Humanized anti-dll3 chimeric antigen receptors and uses thereof | |
| US11479606B2 (en) | Compositions and methods for targeting CD33-expressing cancers | |
| JP2017518071A5 (ru) | ||
| JPWO2019165156A5 (ru) | ||
| JPWO2020180591A5 (ru) | ||
| JPWO2020228825A5 (ru) | ||
| JPWO2021034689A5 (ru) | ||
| JPWO2020061498A5 (ru) |